bioRxivPathology
Depression, GABA and age correlate with the plasma levels of inflammatory markers.
A. K. Bhandage, J. L. Cunningham, Z. Jin, Q. Shhen, S. Bongiovanni, S. V. Korol, M. Syk, M. Kamali-Moghaddam, L. Ekselius, B. Birnir
Abstract
Immunomodulation is increasingly being recognised as a part of mental diseases. Here, we examined if levels of immunological protein markers altered with depression, age or by the inhibitory neurotransmitter gamma-aminobutyric acid (GABA). Analysis of plasma samples from patients with major depressive episode and control blood donors (CBD) revealed expression of 67 inflammatory markers. Thirteen of these markers had augmented levels in patients as compared to CBD. and 21 markers correlated with age of the patients, whereas 10 markers correlated with the age of CBD. Interestingly, CST5 and CDCP1 showed the strongest correlation with age in the patients and in the CBD, respectively. IL-18 was the only marker that correlated with the MADRS-S scores of the patients. Neuronal growth factors (NGFs) were significantly enhanced in plasma from the patients and so was the average plasma GABA concentration. GABA modulated release of seven cytokines in CD3+ stimulated peripheral blood mononuclear cells (PBMC) from the patients. The study reveals significant changes in plasma composition of small molecules during depression and identifies potential peripheral biomarkers of the disease.
- organism: human
- assay: proteomics
- research focus: differential expression
- research focus: cell-cell communication
- approach: statistical model
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- LPS-Induced Inflammation Reduces GABAergic Interneuron markers and Brain-derived Neurotrophic Factor in Mouse Prefrontal Cortex and Hippocampus
Sara Rezaei, Thomas D. Prévot, … Etienne L. Sibille·Brain Behavior & Immunity - HealthPeer-reviewed·Mar 22, 2024
- Assessing 42 inflammatory markers in 321 control subjects and 887 major depressive disorder cases: BMI and other confounders and overall predictive ability for current depression
Timothy R. Powell, Helena Gaspar, … Hong Wang·bioRxiv·May 21, 2018
- Peripheral blood cell immunophenotyping reveals distinct subgroups of inflamed depression
M.-E. Lynall, L. Turner, … E. Bullmore·bioRxiv·Jul 18, 2019
- Basal Ganglia Dopamine Availability and Immune Activation Interact and Relate to Anhedonia Severity among Youth with Depression
Iris Ka-Yi Chat, James W. Murrough, … Erika E. Forbes·bioRxiv·Oct 7, 2026
- Convergent molecular, cellular, and neural signatures of major depressive disorder
Kevin M. Anderson, Meghan A. Collins, … Avram J. Holmes·bioRxiv·Feb 10, 2020
- Gut Microbiota Signatures of Brain and Peripheral gamma-amino butyric acid (GABA) in Healthy Adult Males
Andrea Monteagudo-Mera, Suyi Xie, … Bhismadev Chakrabarti·bioRxiv·Sep 6, 2026